Trained on 9 trillion DNA base pairs from every domain of life, the Evo 2 model can predict disease-causing mutations, ...

Research is shaking up how we think about evolution, suggesting there's a level of predictability influenced by genes and genetic history.

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells. However, most genetic ...

Subscribe to our newsletter for the latest sci-tech news updates. These factors include genetic and age-related blood mutations, smoking and infection by oral bacteria. Published in Cancer Discovery, ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient’s cells. However, most genetic disorders are caused by dozens or even thousands of ...

The gut microbiome—the trillions of bacteria and other microbes that inhabit the gastrointestinal tract—drives a process vital for protecting the colon against tissue injury, according to the findings ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

A bacterium already famous for shrugging off extreme radiation and desiccation has now passed another brutal test: surviving ...

Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies.

An international team of researchers has modified a probiotic yeast to make it safer for use by immunocompromised people, older adults and infants. Testing in an animal model found that the modified ...

Ludamil Alexandrov, and cancer researcher specializing in linking cancer mutations to environmental influences, will oversee $25 million grant from Cancer Grand Challenges.